SM

Shaker A. Mousa

BT Biovec Transfusion: 4 patents #2 of 2Top 100%
BS Bristol-Myers Squibb: 3 patents #1,423 of 3,969Top 40%
KU King Abdulaziz University: 1 patents #315 of 712Top 45%
📍 Wynantskill, NY: #7 of 35 inventorsTop 20%
🗺 New York: #10,487 of 115,490 inventorsTop 10%
Overall (All Time): #347,945 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
10251842 Nanocapsule containing a bioactive compound, and a method of reducing toxicity resulting from cancer therapy Amna Saddiq, Deena S. Mousa 2019-04-09
9956181 Composition of nanoformulated lycopene and method of using the composition Mohammed H. Qari, Mohammed S. Ardawi 2018-05-01
9707318 Compositions of novel bone patch in bone and vascular regeneration Mohammed H. Qari, Mohammed S. Ardawi 2017-07-18
9700042 Nanoformulation of musk-derived bioactive ingredients for nanocosmetic applications Amna Saddiq 2017-07-11
9572831 Composition and method for sulfated non-anticoagulant low molecular weight heparins in cancer and tumor metastasis 2017-02-21
8563053 Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosis Mohammed H. Qari, Mohammed S. Ardawi 2013-10-22
8142992 Platelet preservation package comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier Lakshman R. Sehgal 2012-03-27
8129104 Platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with hemoglobin Lakshman R. Sehgal 2012-03-06
8129103 Use of a platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier Lakshman R. Sehgal 2012-03-06
7964338 Platelet preservation composition containing eptifibatide, a reversible factor IIa inhibitor and a hemoglobin oxygen carrier Lakshman R. Sehgal 2011-06-21
7332161 Treatment of disease with antibodies against high molecular weight kininogen domain 5 Robert W. Colman 2008-02-19
6994852 Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5 Robert W. Colman 2006-02-07
6346517 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders Pancras C. Wong 2002-02-12
6284726 Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5 Robert W. Colman 2001-09-04